Here are the top headlines from Fox Business Flash. Check out what is clicking on FoxBusiness.com.
A ransomware attack on a health tech firm has slowed down some clinical trials, including some treatments and vaccines for coronavirus.
Target was a Philadelphia company that sells software used in hundreds of clinical trials, according to the New York Times.
No patient was affected.
Get Fox Business on the go by clicking here
The attack on EResearchT technology (ERT) began two weeks ago when employees learned they had been locked out of their data by ransomware.
The companies hit were IQVA, a contract research institute that helped conduct the trial of AstraZeneca’s covid vaccine, and Bristol Myers Squibb, a consortium of companies developing rapid testing for the virus.
The ERT did not say how many clinical trials were affected.
AIDS to the left of Trump’s gestures ‘Real CONCREDDED’ has improved in the first phase, Meadows says
According to its website, the company was involved in three-quarters of tests last year following drug approval by the Food and Drug Administration.
On Friday, Drew Bustos, vice president of marketing ERT, confirmed that Reponsomware will be released on Sept. 20. Has captured its systems.
Trump’s Coronavirus Infection Optimized ‘CT October Surprise,’ But Impact Enigma Remains
As a precaution, Bustos said, the company took its systems offline that day and reported it to outside cybersecurity experts as well as the FBI.
The company said it was too early to say who was behind the attack.
A spokesman declined to say whether the company had paid the extortionists.
Click here to read more on Fox Business
According to the Times, in the last 18 months, U.S. The incidents led to more than 1,000 ransomware attacks on cities, counties and hospitals.
